Literature DB >> 17283370

Immunohistochemical evidence for the presence of glucokinase in the gonadotropes and thyrotropes of the anterior pituitary gland of rat and monkey.

Robert L Sorenson1, Laurence E Stout, T Clark Brelje, Thomas L Jetton, Franz M Matschinsky.   

Abstract

A recent report provides new evidence for the presence of glucokinase (GK) in the anterior pituitary. In the present study, immunohistochemistry was used to identify the cells containing GK in the pituitary of rats and monkeys. In rats, GK was detected as a generalized cytoplasmic staining in a discrete population of cells in the anterior pituitary. In colocalization experiments, the majority of cells expressing follicle-stimulating hormone (FSH) or luteinizing hormone (LH) also contained GK. In addition to the gonadotropes, GK was observed in a subpopulation of corticotropes and thyrotropes. GK was not detected in cells expressing growth hormone or prolactin. In monkeys, GK was also observed in a discrete population of cells. Intracellular distribution differed from the rat in that GK in most cells was concentrated in a perinuclear location that appeared to be associated with the Golgi apparatus. However, similar to rats, colocalization experiments showed that the majority of cells expressing FSH or LH also contained GK. In addition to the gonadotropes, GK was observed in a subpopulation of corticotropes and thyrotropes. In the monkey, only a few cells had generalized cytoplasmic staining for GK. These experiments provide further evidence for the presence of GK in the anterior pituitary. Although some corticotropes and thyrotropes contained GK, the predominant cell type expressing GK was gonadotropes. In view of the generally accepted role of GK as a glucose sensor in a variety of cells including the insulin-producing pancreatic beta-cells as the prototypical example, it is hypothesized that hormone synthesis and/or release in pituitary cells containing GK may be directly influenced by blood glucose.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17283370     DOI: 10.1369/jhc.6A7117.2007

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  9 in total

1.  Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics.

Authors:  Nicolai M Doliba; Wei Qin; Habiba Najafi; Chengyang Liu; Carol W Buettger; Johanna Sotiris; Heather W Collins; Changhong Li; Charles A Stanley; David F Wilson; Joseph Grimsby; Ramakanth Sarabu; Ali Naji; Franz M Matschinsky
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-09-27       Impact factor: 4.310

2.  Mutational analysis of allosteric activation and inhibition of glucokinase.

Authors:  Bogumil Zelent; Stella Odili; Carol Buettger; Dorothy K Zelent; Pan Chen; Deborah Fenner; Joseph Bass; Charles Stanley; Monique Laberge; Jane M Vanderkooi; Ramakanth Sarabu; Joseph Grimsby; Franz M Matschinsky
Journal:  Biochem J       Date:  2011-12-01       Impact factor: 3.857

3.  Aryl hydrocarbon receptor activation in lactotropes and gonadotropes interferes with estradiol-dependent and -independent preprolactin, glycoprotein alpha and luteinizing hormone beta gene expression.

Authors:  Jinyan Cao; Heather B Patisaul; Sandra L Petersen
Journal:  Mol Cell Endocrinol       Date:  2010-12-25       Impact factor: 4.102

Review 4.  Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy?

Authors:  Sachin K Majumdar; Silvio E Inzucchi
Journal:  Endocrine       Date:  2013-01-25       Impact factor: 3.633

Review 5.  Homotropic allosteric regulation in monomeric mammalian glucokinase.

Authors:  Mioara Larion; Brian G Miller
Journal:  Arch Biochem Biophys       Date:  2011-11-15       Impact factor: 4.013

6.  The transcription factor Rfx3 regulates beta-cell differentiation, function, and glucokinase expression.

Authors:  Aouatef Ait-Lounis; Claire Bonal; Queralt Seguín-Estévez; Christoph D Schmid; Philipp Bucher; Pedro L Herrera; Bénédicte Durand; Paolo Meda; Walter Reith
Journal:  Diabetes       Date:  2010-04-22       Impact factor: 9.461

7.  Selective deletion of leptin receptors in gonadotropes reveals activin and GnRH-binding sites as leptin targets in support of fertility.

Authors:  Noor Akhter; Tyler CarlLee; Mohsin M Syed; Angela K Odle; Michael A Cozart; Anessa C Haney; Melody L Allensworth-James; Helen Beneš; Gwen V Childs
Journal:  Endocrinology       Date:  2014-07-24       Impact factor: 4.736

8.  Fasting and glucose effects on pituitary leptin expression: is leptin a local signal for nutrient status?

Authors:  Christopher Crane; Noor Akhter; Brandy W Johnson; Mary Iruthayanathan; Farhan Syed; Akihiko Kudo; Yi-Hong Zhou; Gwen V Childs
Journal:  J Histochem Cytochem       Date:  2007-06-26       Impact factor: 2.479

Review 9.  Assessing the potential of glucokinase activators in diabetes therapy.

Authors:  Franz M Matschinsky
Journal:  Nat Rev Drug Discov       Date:  2009-04-17       Impact factor: 84.694

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.